Please ensure Javascript is enabled for purposes of website accessibility

Patient dosed with drug made with RoosterBio’s technology (access required)

A human patient has been dosed for the first time with a drug that was made using a Frederick cell manufacturing platform company's technology. RoosterBio Inc. announced that its CliniControl cell and media systems were used to make the drug for clinical research by a customer it would not identify to The Daily Record. It's the first ...

To purchase a reprint of this article, contact [email protected].